Procurement Summary
Country : Spain
Summary : Supply of Biosimilar Medicines Ustekinumab, Ranibizumab and Eculizumab for the Huesca Sector.
Deadline : 28 Apr 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 116685274
Document Ref. No. : 189125-2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 436100
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Supply of biosimilar medicines ustekinumab, ranibizumab and eculizumab for the huesca sector.
Validity of September 1, 2025 to August 31, 2026 or 12 months from its formalization.Ustekinumab 45 mg (feathers/syringes)
ranibizumab 10 mg/ml 0.23 ml (2.3 mg) (roads)
eculizumab 300 mg (roads)
doc title: supply of biosimilar medications usimilar usimilar, ranibizumab and eculizumab for the huesca sector.
Contract type:supplies
Document Type: Contract Notice
Reference Number: SAS_HU_2025_17
Contract Type: supplies
Estimated Value: 436100 - EUR
Authority Type: ra
Doc Title: Suministro de medicamentos biosimilares Ustekinumab, Ranibizumab y Eculizumab para el Sector de Huesca.
Dispatch Date: 2025-03-21
Publish Date:2025-03-24
Submission Date: 2025-04-28
Documents
Tender Notice